Innospec Statistics
Total Valuation
Innospec has a market cap or net worth of $2.38 billion. The enterprise value is $2.13 billion.
Important Dates
The next estimated earnings date is Thursday, May 8, 2025, after market close.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | Nov 18, 2024 |
Share Statistics
Innospec has 24.96 million shares outstanding. The number of shares has increased by 0.39% in one year.
| Current Share Class | 24.96M |
| Shares Outstanding | 24.96M |
| Shares Change (YoY) | +0.39% |
| Shares Change (QoQ) | -0.61% |
| Owned by Insiders (%) | 1.17% |
| Owned by Institutions (%) | 97.90% |
| Float | 24.65M |
Valuation Ratios
The trailing PE ratio is 66.88 and the forward PE ratio is 15.85. Innospec's PEG ratio is 2.17.
| PE Ratio | 66.88 |
| Forward PE | 15.85 |
| PS Ratio | 1.32 |
| Forward PS | 1.23 |
| PB Ratio | 2.01 |
| P/TBV Ratio | 3.11 |
| P/FCF Ratio | 16.59 |
| P/OCF Ratio | 12.87 |
| PEG Ratio | 2.17 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 28.11, with an EV/FCF ratio of 14.89.
| EV / Earnings | 59.84 |
| EV / Sales | 1.15 |
| EV / EBITDA | 28.11 |
| EV / EBIT | 65.15 |
| EV / FCF | 14.89 |
Financial Position
The company has a current ratio of 2.58, with a Debt / Equity ratio of 0.04.
| Current Ratio | 2.58 |
| Quick Ratio | 1.70 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.44 |
| Debt / FCF | 0.31 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 3.01% and return on invested capital (ROIC) is 1.66%.
| Return on Equity (ROE) | 3.01% |
| Return on Assets (ROA) | 1.19% |
| Return on Invested Capital (ROIC) | 1.66% |
| Return on Capital Employed (ROCE) | 2.40% |
| Revenue Per Employee | $753,224 |
| Profits Per Employee | $14,531 |
| Employee Count | 2,450 |
| Asset Turnover | 1.07 |
| Inventory Turnover | 4.33 |
Taxes
In the past 12 months, Innospec has paid $5.60 million in taxes.
| Income Tax | 5.60M |
| Effective Tax Rate | 13.59% |
Stock Price Statistics
The stock price has decreased by -26.62% in the last 52 weeks. The beta is 1.06, so Innospec's price volatility has been similar to the market average.
| Beta (5Y) | 1.06 |
| 52-Week Price Change | -26.62% |
| 50-Day Moving Average | 105.56 |
| 200-Day Moving Average | 113.20 |
| Relative Strength Index (RSI) | 35.64 |
| Average Volume (20 Days) | 341,225 |
Short Selling Information
The latest short interest is 262,049, so 1.05% of the outstanding shares have been sold short.
| Short Interest | 262,049 |
| Short Previous Month | 289,000 |
| Short % of Shares Out | 1.05% |
| Short % of Float | 1.06% |
| Short Ratio (days to cover) | 1.82 |
Income Statement
In the last 12 months, Innospec had revenue of $1.85 billion and earned $35.60 million in profits. Earnings per share was $1.42.
| Revenue | 1.85B |
| Gross Profit | 542.90M |
| Operating Income | 32.70M |
| Pretax Income | 191.80M |
| Net Income | 35.60M |
| EBITDA | 75.80M |
| EBIT | 32.70M |
| Earnings Per Share (EPS) | $1.42 |
Full Income StatementBalance Sheet
The company has $289.20 million in cash and $44.90 million in debt, giving a net cash position of $244.30 million or $9.79 per share.
| Cash & Cash Equivalents | 289.20M |
| Total Debt | 44.90M |
| Net Cash | 244.30M |
| Net Cash Per Share | $9.79 |
| Equity (Book Value) | 1.22B |
| Book Value Per Share | 48.53 |
| Working Capital | 585.20M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $184.50 million and capital expenditures -$41.40 million, giving a free cash flow of $143.10 million.
| Operating Cash Flow | 184.50M |
| Capital Expenditures | -41.40M |
| Free Cash Flow | 143.10M |
| FCF Per Share | $5.73 |
Full Cash Flow StatementMargins
Gross margin is 29.42%, with operating and profit margins of 1.77% and 1.93%.
| Gross Margin | 29.42% |
| Operating Margin | 1.77% |
| Pretax Margin | 2.23% |
| Profit Margin | 1.93% |
| EBITDA Margin | 4.11% |
| EBIT Margin | 1.77% |
| FCF Margin | 7.75% |